You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SUV

Showing 1 - 25 of 1,112
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Validity of Mediastinal Blood Pool SUV Ratio

Not yet recruiting
  • Validity of Blood Pool SUV Ratio in Identification of Malignancy in Case of Diseased Liver
  • F18 FDG
  • (no location specified)
Feb 22, 2022

Cancer Trial in Montreal (PSMA PET/CT)

Enrolling by invitation
  • Cancer
  • PSMA PET/CT
  • Montreal, Quebec, Canada
    Jewish General Hospital
Dec 9, 2021

PET/MR for Clinical Trial Qualification

Completed
  • Positron Emission Tomography-Magnetic Resonance (PET-MR)
  • Positron Emission Test / Magnetic Resonance (PET/MR)
  • Positron Emission Test / Computed Tomography (PET/CT)
  • Cleveland, Ohio
    University Hospitals Seidman Cancer Center, Case Comprehensive C
Oct 28, 2021

Dose Response Relationship, Drug Trial in Winston-Salem (F-18 FDG PET)

Terminated
Has Results
  • Dose Response Relationship, Drug
  • F-18 FDG PET
  • Winston-Salem, North Carolina
    Wake Forest Baptist Health
Mar 9, 2022

Insomnia Trial in Japan (Lemborexant (LEM) 5 mg (Z-Drug-mono cohort), Lemborexant (LEM) 5 mg (SUV-mono cohort), Lemborexant

Recruiting
  • Insomnia
  • Lemborexant (LEM) 5 mg (Z-Drug-mono cohort)
  • +3 more
  • Kitakyushu, Fukuoka, Japan
  • +8 more
Oct 2, 2021

Primary Non Small Cell Lung Carcinoma Standardized F18-FDG

Active, not recruiting
  • Non Small Cell Lung Carcinoma
    • Ath, Belgium
    • +5 more
    Aug 20, 2021

    Neuroendocrine Tumors Trial in Montréal (68Ga-DOTATATE PET/CT)

    Enrolling by invitation
    • Neuroendocrine Tumors
    • 68Ga-DOTATATE PET/CT
    • Montréal, Quebec, Canada
      Jewish General Hospital
    Feb 8, 2021

    Breast Cancer Trial in United States (Positron emission tomography (PET), Trastuzumab, Pertuzumab)

    Active, not recruiting
    Has Results
    • Breast Cancer
    • Positron emission tomography (PET)
    • +2 more
    • Birmingham, Alabama
    • +9 more
    Jan 20, 2023

    Pancreatic Adenocarcinoma Trial in Dallas (drug, procedure, other)

    Completed
    Has Results
    • Pancreatic Adenocarcinoma
    • 3'-deoxy-3'-[F-18] fluorothymidine: [F-18]FLT
    • +3 more
    • Dallas, Texas
      UT Southwestern Medical Center
    Oct 10, 2022

    Alcohol Use Disorder Trial in Columbus (Suvorexant, Placebo)

    Recruiting
    • Alcohol Use Disorder
    • Columbus, Ohio
      The Ohio State University
    Dec 11, 2022

    Post-Acute COVID-19, Post-Acute COVID-19 Infection, Post-Acute COVID-19 Syndrome Trial in Groningen

    Recruiting
    • Post-Acute COVID-19
    • +3 more
      • Groningen, Netherlands
        University Medical Center Groningen
      Aug 3, 2023

      Coronary Artery Disease Trial in Basel (99mTc-sestamibi myocardial perfusion SPECT, 82Rb-Chloride myocardial perfusion PET with

      Recruiting
      • Coronary Artery Disease
      • 99mTc-sestamibi myocardial perfusion SPECT
      • 82Rb-Chloride myocardial perfusion PET with CCTA
      • Basel, Switzerland
        Clinic of Radiology & Nuclear Medicine, University Hospital of B
      Dec 7, 2021

      Pituitary Tumours Trial in Göteborg (Gallium-68 DOTATOC PET)

      Terminated
      • Pituitary Tumours
      • Gallium-68 DOTATOC PET
      • Göteborg, Sweden
        Center of Endocrinology and Metabolism, Sahlgrenska university H
      Mar 15, 2022

      FAPI in Rectal Cancer TNT

      Not yet recruiting
      • Rectal Neoplasms Malignant
      • Ga-68 FAPI
      • Taoyuan, Taiwan
        Chang Gung Memorial Hospital
      Nov 27, 2023

      Stage III NSCLC, Locally Advanced, Unresectable Trial (standard Radiotherapy, Chemotherapy, Immunotherapy)

      Not yet recruiting
      • Stage III Non-small Cell Lung Cancer
      • +2 more
      • standard Radiotherapy
      • +3 more
      • (no location specified)
      Oct 20, 2023

      Digestive System Neuroendocrine Tumor G1, Digestive System Neuroendocrine Tumor G2, Metastatic Digestive System Neuroendocrine

      Not yet recruiting
      • Digestive System Neuroendocrine Tumor G1
      • +5 more
      • Tumor Debulking
      • +5 more
      • Nashville, Tennessee
        Vanderbilt University/Ingram Cancer Center
      Aug 23, 2023

      Crohn's Disease Trial in Stockholm (AZD7798, [11C]AZ14132516)

      Not yet recruiting
      • Crohn's Disease
      • Stockholm, Sweden
        Research Site
      Sep 22, 2023

      Breast Cancer, Brain Metastases Trial in New York (Brain Imaging with 18F-FES)

      Not yet recruiting
      • Breast Cancer
      • Brain Metastases
      • Brain Imaging with 18F-FES
      • New York, New York
        New York-Presbyterian/Weill Cornell Medical Center
      Oct 2, 2023

      99mTc-DARPinG3 SPECT/CT for Non-invasive HER2-AX in Breast

      Enrolling by invitation
      • Breast Cancer Female
      • 99mTc-DARPinG3 SPECT/CT
      • Tomsk, Russian Federation
        Russia Tomsk NRMC
      Jan 23, 2023

      Spondyloarthritis, Axial Spondyloarthritis, Ankylosing Spondylitis Trial in Xiamen (Drug: 68Ga-FAPI)

      Recruiting
      • Spondyloarthritis
      • +2 more
      • Drug: 68Ga-FAPI
      • Xiamen, Fujian, China
        The first affiliated hospital of Xiamen University
      Aug 13, 2023

      FUR to Quantify Tumor Glucose Consumption in Oncologic PET

      Not yet recruiting
      • Lung Cancer
      • Lymphoma
      • FDG PET/CT
      • Maastricht, Limburg, Netherlands
        Academisch ziekenhuis Maastricht
      Jan 31, 2023

      Intestinal Fibrosis in Crohn's Disease Based on 18F-FAPI PET

      Recruiting
      • Crohn Disease
        • Chongqing, Chongqing, China
          Department of Nuclear Medicine, Daping Hospital of Army Medical
        Apr 20, 2023

        Pheochromocytoma, Paraganglioma Trial in Philadelphia ([18F]FluorThanatrace ([18F]FTT))

        Not yet recruiting
        • Pheochromocytoma
        • Paraganglioma
        • [18F]FluorThanatrace ([18F]FTT)
        • Philadelphia, Pennsylvania
          Abramson Cancer Center of the University of Pennsylvania
        Dec 1, 2022

        Parkinson's Disease, Multiple System Atrophy, Dementia With Lewy Bodies Trial (C11-SY08)

        Not yet recruiting
        • Parkinson's Disease
        • +3 more
        • (no location specified)
        Oct 24, 2023

        Idiopathic Pulmonary Fibrosis Trial in Paris (18FDG-PET scan)

        Recruiting
        • Idiopathic Pulmonary Fibrosis
        • 18FDG-PET scan
        • Paris, France
          Service de Pneumologie A Centre constitutif de référence des mal
        Oct 3, 2022